Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Long-acting beta(2)-agonists and inhaled corticosteroids can be used as maintenance therapy by patients with moderate to severe chronic obstructive pulmonary disease. These interventions are often taken together in a combination inhaler. However, the relative added value of the two individual components is unclear.